Incyte (INCY) Revenue (2010 - 2026)
Incyte (INCY) recorded Revenue of $1.67 billion in Q2 2026, up 37.7% from $1.22 billion a year earlier and up 31.5% from the prior quarter.
Powered by 
Analysis
Incyte (INCY) Revenue (2010 - 2026) Analysis & Trends
On a TTM basis, Incyte's Revenue came in at $5.82 billion as of Jun 30, 2026, up 26.9% year-over-year; for FY2025, it came in at $5.14 billion, up 21.2% from FY2024.
- Annual Revenue has increased for 14 straight years, with a five-year compound annual growth rate of 14.0% (FY2020 to FY2025).
- Across earlier years, Revenue came in at $4.24 billion in FY2024 (+14.8%), $3.7 billion in FY2023 (+8.9%), $3.39 billion in FY2022 (+13.7%) and $2.99 billion in FY2021 (+12.0%).
- The Q2 2026 figure is the highest quarterly Revenue in data going back to Q1 2010.
- On a year-over-year basis, Revenue has increased for 33 consecutive quarters, with growth averaging 22.8% over the last eight quarters.
- Over the past five years, the year-over-year growth in Revenue ranged from 1.3% (Q3 2022) to 37.7% (Q2 2026).
- Per Business Quant, the preceding three quarters came in at $1.27 billion (Q1 2026), $1.51 billion (Q4 2025) and $1.37 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Incyte | 24.39 Bn | 9.33 Bn | 1.57 Bn | 1.67 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.67 Bn |
| Mar 31, 2026 | 1.27 Bn |
| Dec 31, 2025 | 1.51 Bn |
| Sep 30, 2025 | 1.37 Bn |
| Jun 30, 2025 | 1.22 Bn |
| Mar 31, 2025 | 1.05 Bn |
| Dec 31, 2024 | 1.18 Bn |
| Sep 30, 2024 | 1.14 Bn |
| Jun 30, 2024 | 1.04 Bn |
| Mar 31, 2024 | 880.89 Mn |
| Dec 31, 2023 | 1.01 Bn |
| Sep 30, 2023 | 919.03 Mn |
| Jun 30, 2023 | 954.61 Mn |
| Mar 31, 2023 | 808.67 Mn |
| Dec 31, 2022 | 926.70 Mn |
| Sep 30, 2022 | 823.30 Mn |
| Jun 30, 2022 | 911.40 Mn |
| Mar 31, 2022 | 733.24 Mn |
| Dec 31, 2021 | 862.85 Mn |
| Sep 30, 2021 | 812.99 Mn |
API Access
Incyte Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();